Page 11 - Summa Health Cancer Institute 2016 Outcomes
P. 11

Which Summa Health Medical Group
practices are participating?

•	 Medical Oncology
•	 Gynecology Oncology
•	 Breast Center
•	 Urology

What do feedback reports from CMS show thus far?

Feedback from CMS for patients treated at Summa Health
in 2016 is summarized below:

Metric                                SHMG OCM practices  Patients treated at Summa Health
                                                          have equivalent outcomes compared
Number of Medicare beneficiaries      310     484         to other practices nationally including
                                                          large academic centers at a lower
Medicare expenditures for all         $4,505  $4,676      cost. They have less hospitalizations
services per beneficiary per month    20.4    21.3        and chemotherapy in their last few
                                      17.4    15.2        months of life and spend more
Number of inpatient admissions, all                       days on hospice which gives them
cause [per 100 beneficiaries]         $197    $270        opportunity to be more comfortable
                                                          and spend quality time with family.
Number of ED visits not leading to    $2,082  $2,300
admission or observation [per 100                         What are some areas of improvement?
beneficiaries]
                                                          Emergency Department visits is one key area. Summa
Ancillary services in all ambulatory                      Health Cancer Research initiated an investigator initiated
settings per beneficiary per month                        trial titled “Prospective Randomized Trial to Assess Relative
(includes laboratory and imaging)                         Effectiveness of Two Educational Methods on Reducing
                                                          Emergency Room Visits and Hospital Admissions in
Drugs per beneficiary per month                           Patients Receiving First Line Chemotherapy.” Other
                                                          measures include effective use of Oncology Infusion
Mortality (all beneficiaries)         4.7%    5.0%        Centers for hydration and transfusion needs and same-
                                                          day access to outpatient appointments for patients calling
End of Life Care                                          in with symptoms.

Any hospice care within 30 days       71.8%   65.2%       Conclusion
before death: Percentage of deaths    26.4    18.9
                                      42%     54.9%       Achieving high value for patients must become the
Days of hospice care within 90 days   22.6%   26.6%       overarching goal of healthcare delivery, with value defined
before death                          7.4%    12.7%       as health outcomes achieved per dollar spent. Summa
                                                          Health Cancer Institute is not just embracing it, but
Percentage of hospital use within                         leading from the front.
30 days before death

Percentage in the intensive care
unit within 30 days before death

Percentage receiving
chemotherapy within 2 weeks
before death

Summa Health Cancer Institute’s OCM management team includes Sameer Mahesh, MD, Oncologist and Principal
Investigator OCM; Joseph Koenig, MD, Oncologist and Medical Director, Cooper Cancer Center; Gilbert Padula, MD,
Medical Director, Summa Health Cancer Institute; Elise Longfellow, RN, OCM Program Manager; Karen Speckman, RN, OCM
Program Coordinator; David White, Sr. Solution Architect, IT; David Westermann, Clinical Systems Analyst, IT; Jamie Kish,
Sr. Management Engineer, Performance Solutions; Mindi Reinbolt, Practice Manager, Summa Health Medical Group; Robin
Lotz, MBA, Manager, Breast Imaging Services; Jody Norris, Practice Manager, Summa Health Medical Group; Eileen Simcox,
RN, Clinical Coordinator, Gynecologic Oncology; Karen Gil, Scientific Director, Research Administration; and Dawn Pittinger,
Manager, Clinical Research Billing.

                                                                                                                              11
   6   7   8   9   10   11   12   13   14   15   16